This event has ended

Breaking the TB Cycle: Innovations in Diagnosis & Treatment

Rutgers Global Tuberculosis Institute and Janssen Pharmaceuticals

Wednesday, May 15, 2013 from 8:30 AM to 3:30 PM (PDT)

Shrewsbury, MA

Breaking the TB Cycle: Innovations in Diagnosis & Treatment

Registration Information

Type End     Quantity
Breaking the TB Cycle: Innovations in Diagnosis & Treatment   more info Ended Free  

Who's Going

Loading your connections...

Event Details

Breaking the TB Cycle:

Innovations in Diagnosis & Treatment

May 15, 2013

 

Course Location

Hoagland Pincus Conference Center

222 Maple Avenue

Shrewsbury, MA 01545

 

Sponsored By

New Jersey Medical School Global Tuberculosis Institute,

Bureau of Infectious Diseases, Massachusetts Department of Public Health, and New England TB Consortium

This activity is supported in part by an educational grant from the Centers for Disease Control and Prevention, Division of Tuberculosis Elimination

The New Jersey Medical School Global Tuberculosis Institute is the tuberculosis Regional Training and Medical Consultation Center for the northeast United States

COURSE DESCRIPTION & OVERALL GOAL

The purpose of this training is to strengthen providers’ knowledge of TB diagnosis and treatment. The conference will provide an opportunity to discuss current and emerging issues in TB, as well as the management of routine and complicated TB cases. The format includes lectures, discussions, and interactive case studies.

WHO SHOULD ATTEND

This conference is designed for clinicians who diagnose and treat persons with latent TB infection and disease. Physicians, physician assistants and nurse practitioners are welcome to attend.

WHY COURSE IS NEEDED

As the incidence of tuberculosis continues to decline, maintaining clinical expertise in TB is particularly challenging. Therefore, ongoing training and education are important for clinicians so they can develop and enhance skills in the diagnosis of TB, follow recommended treatment guidelines, and interact effectively with public health agencies. This type of training is also important for new clinicians working in TB control or other settings.

OBJECTIVES

Upon completion of this course, participants should be able to:

  • Explain the dynamics of TB transmission and the effectiveness of novel infection control interventions
  • Discuss the pros and cons of interferon gamma release assays for diagnosing latent TB infection
  • Describe the current problem of TB drug and Tubersol shortages and the implications for TB and LTBI patient care
  • Assess recent advances in the development of new drugs that may offer shorter, simpler and safer TB treatment regimens
  • Apply current approaches for the diagnosis, treatment and management of routine and complex TB cases

COURSE REQUIREMENTS

In order to meet the learning objectives and receive continuing education credits, participants are required to attend the entire conference and complete an evaluation. A post-course follow up evaluation will be sent to participants within 2 months of the conference.

FACULTY

W. Kemper Alston, MD                                                                                                          Professor of Medicine, University of Vermont

John Bernardo, MD                                                                                                          Professor of Medicine, Boston University School of Medicine

Mark Lobato, MD                                                                                                                         TB Medical Officer, Centers for Disease Control & Prevention - Division of TB Elimination

Katherine McGowan, MD                                                                                                          Chief, Division of Infectious Disease, Brigham & Women's Faulkner Hospital 

Edward Nardell, MD                                                                                                          Associate Professor, Harvard Medical School

Nira Pollock, MD                                                                                                               Assistant Professor, Harvard Medical School

Lynn Sosa, MD                                                                                                                      Deputy State Epidemiologist, Connecticut Department of Public Health

Marie Turner, MD                                                                                                                       Medical Director, TB Treatment Unit, Lemuel Shattuck Hospital

PLANNING COMMITTEE

John Bernardo, MD                                                                                                          Professor of Medicine, Boston University School of Medicine

Patricia Iyer, RN, MSN                                                                                                          Director of Patient Management/TB Training Focal Point, Massachusetts Department of Public Health

Anita Khilall, MPH                                                                                                                      Senior Training & Consultation Specialist, NJMS Global Tuberculosis Institute

Mark Lobato, MD                                                                                                                         TB Medical Officer, Centers for Disease Control & Prevention - Division of TB Elimination

Lynn Sosa, MD                                                                                                                      Deputy State Epidemiologist, Connecticut Department of Public Health

Dalit Wolfe, RN, BSN, MPH                                                                                                         TB Control Coordinator, Maine Center for Disease Control & Prevention

AGENDA

8:15 am            Registration

9:00 am            Welcome & Overview

9:15 am            Current Topics in TB Transmission & Infection Control—E. Nardell

10:00 am          IGRAs: Pros & Cons for Expanded Use

                        Panel: J. Bernardo, E. Nardell, N. Pollock, L. Sosa, & M. Turner

11:00 am          Break

11:10 am          Coming up Short: Interruptions in TB Drug Supply—M. Lobato

11:45 am          Emerging Therapies for TB—K. Alston

12:30 pm          Lunch

1:30 pm            Practical Aspects of Implementing the New 12-Dose Regimen—L. Sosa

2:15 pm            Case Presentations—M. Turner & K. McGowan

3:15 pm            Closing Remarks & Adjourn

CONTINUING EDUCATION INFORMATION

The Bureau of Infectious Disease, Massachusetts Department of Public Health, designates this Live activity for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Bureau of Infectious Disease, Massachusetts Department of Public Health is accredited by the Massachusetts Medical Society to provide continuing medical education for physicians.

This activity is has been planned and implemented in accordance with the Essential Areas and policies of the Massachusetts Medical Society for Continuing Medical Education through the Joint Sponsorship of the Bureau of Infectious Disease, Massachusetts Department of Public Health and the New Jersey Medical School Global Tuberculosis Institute and the New England TB Consortium.

This program has been offered by the Bureau of Infectious Disease, Massachusetts Department of Public Health. A maximum of 4.75 contact hours for this program will be provided in accordance with the regulations governing continuing education requirements for the following MA Boards of Registration:

Board of Registration in Nursing (244CMR 5.00)

REGISTRATION INFORMATION & FEE

The registration deadline is May 1, 2013.

The conference fee is $30.00 and payment must be received by May 6th. Acceptable forms of payment are check or money order made payable to NJMS Global Tuberculosis Institute and mailed to:

NJMS Global Tuberculosis Institute
225 Warren Street
Newark, NJ 07103 

Attn: Anita Khilall

TRAVEL INFORMATION

The conference will be held at:

Hoagland Pincus Conference Center

222 Maple Avenue

Shrewsbury, MA 01545

From Main Campus/Downtown Worcester:

Take Rout 9 East over the Lake Quinsigamond Bridge. At third set of traffic lights after the bridge, bear left onto Maple Avenue (intersection marked by Fairlawn Shopping Center, Chili’s Restaurant). Follow Maple Avenue to top of hill. Turn left at the maroon sign for University of Massachusetts Medical School Worcester Foundation Campus. The Hoagland Pincus Conference Center is on the right.

From Route 9 West:

Westbound from Westborough Route 495: proceed West past Route 140 Shrewsbury, continue to the second stop light. This is Oak Street; there will be a bowling alley on the right. Turn right on Oak Street and proceed until you reach a stop sign. This is Maple Avenue. The entrance to the conference center is directly across the street. The Hoagland Pincus Conference Center is the first building on the right.

From the Mass Pike (I-90):

Westbound from Boston: Take exit 11A to Route 495 North to Route 9 West.

Eastbound from Springfield: Take Exit 10 to Route 290 East.

From I-290:

Eastbound from Auburn: Proceed on Route 290 East to Exit 22 – Main Street, Shrewsbury. Take exit 22, at end of ramp take a right onto Main Street.

Westbound from Marlborough: Proceed on Route 290 West to Exit 22 – Main Street, Shrewsbury. Take exit 22, at end of the ramp take a left onto Main Street.

Once on Main Street, Shrewsbury:

Proceed on Main Street through the first set of lights and up the hill. Take right onto Gage Lane (the first right after passing St. John’s High School). Follow Gage Lane to the end. Turn right onto Maple Avenue. Proceed one half mile, turn right at the maroon sign for University of Massachusetts Medical School Worcester Foundation Campus. The Hoagland Pincus Conference Center is the first building on the right.

CANCELLATION INFORMATION

There is no cancellation fee, however, registrants who are unable to attend may cancel up to 2 weeks prior to the conference for a full refund. Refunds cannot be given to registrants who do not cancel in advance. If you are unable to attend, please inform us as soon as possible so that others may be accommodated.

 

If you require an accommodation because of a disability, or if you have any additional needs or other questions, please contact Anita Khilall at (973) 972-9102, or send an email to khilalan@umdnj.edu

Have questions about Breaking the TB Cycle: Innovations in Diagnosis & Treatment? Contact Rutgers Global Tuberculosis Institute and Janssen Pharmaceuticals

When & Where



Hoagland Pincus Conference Center
222 Maple Avenue
Shrewsbury, MA 01545

Wednesday, May 15, 2013 from 8:30 AM to 3:30 PM (PDT)


  Add to my calendar

Organizer

Rutgers Global Tuberculosis Institute and Janssen Pharmaceuticals

  Contact the Organizer

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.